# Combined Treatment of Resistant Hypertension and Atrial Fibrillation

> **NCT01117025** · PHASE2 · COMPLETED · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 26 (actual)

## Conditions studied

- Hypertension, Resistant to Conventional Therapy
- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Circumferential PV isolation
- **PROCEDURE:** Circumferential PVI+renal denervation

## Key facts

- **NCT ID:** NCT01117025
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-08
- **Final completion:** 2012-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117025, "Combined Treatment of Resistant Hypertension and Atrial Fibrillation". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT01117025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*